SpectrumDNA (SPXA) Aktie Kurs

SpectrumDNA Kurs

NYSE·LUKKET
0,01
​
Markedet lukket

Omsætningen er vokset med 37,8 % om året de seneste 3 år til 141.250,00 USD. SpectrumDNAs nettoavance ligger på -1.392,5 %, op fra -3.397,4 % for flere år siden.

SpectrumDNA aktiekurs

Hent disse data via Eulerpool API

100.000 requests/md. gratis · intet kreditkort

SpectrumDNA aktie og aktieanalyse

SpectrumDNA Inc er et selskab, der specialiserer sig i udvikling og markedsføring af genetiske tests og analyser. Selskabet blev grundlagt i 2013, har hovedkvarter i Austin, Texas, og er en af de førende virksomheder inden for DNA-analyse. Historien bag SpectrumDNA går tilbage til grundlæggerne, Dr. Jamie Teumer og Dr. João Silveira. Begge har mange års erfaring inden for genetik og molekylærbiologi og har arbejdet med talrige forskningsprojekter. Deres mål var at gøre genetik tilgængeligt for alle og forbedre sundhedsplejen. Med denne drivkraft grundlagde de SpectrumDNA og begyndte at omsætte deres idé til handling. SpectrumDNAs forretningsmodel er baseret på oprettelse af genetiske tests og analyser, der giver folk mulighed for at kende deres personlige risiko for visse sygdomme eller tilstande og tage målrettede forebyggende foranstaltninger. SpectrumDNA samarbejder tæt med læger og andre sundhedseksperter om at fortolke og implementere resultaterne og anbefalingerne fra testene. SpectrumDNA tilbyder en række forskellige genetiske tests og analyser, der retter sig mod forskellige områder af sundhed og velvære. Disse inkluderer tests til identificering af genetiske risikofaktorer for kræft, hjerte-kar-sygdomme, Alzheimer og Parkinson, samt tests til forudsigelse af adfærdsmæssige træk og fysiske egenskaber såsom laktoseintolerance eller hårfarve. Virksomheden har også sin egen forsknings- og udviklingsafdeling, der konstant arbejder på at fremskynde og forbedre testmetoder og teknologier. Dette sikrer, at kunder hos SpectrumDNA altid modtager den nyeste og mest præcise information. SpectrumDNA har også specialiseret sig i udviklingen af produkter baseret på sine kunders genetiske profiler. Disse inkluderer personligt tilpassede kosttilskud skræddersyet efter kundens individuelle behov samt personlige træningsplaner baseret på kundens genetiske træk. Senest har SpectrumDNA også fokuseret sin opmærksomhed på anvendelsen af genetik i skønhedsindustrien. Virksomheden har udviklet en procedure, der muliggør analyse af hudkvalitet og aldringsproces baseret på kundens genetiske profil. Baseret på denne analyse oprettes et personligt hudplejeprogram, der er skræddersyet til kundens individuelle behov og mål. Samlet set er SpectrumDNA en førende virksomhed inden for feltet DNA-analyse og specialiserer sig i personlig sundhedspleje. Gennem tæt samarbejde med læger og andre sundhedsudbydere samt konstant fremrykning og forbedring af dens teknologier og produkter gør SpectrumDNA det muligt for sine kunder at forbedre deres sundhed og velvære på en personlig og effektiv måde.

Hyppigt stillede spørgsmål om SpectrumDNA-aktien

The business model of SpectrumDNA Inc revolves around providing advanced genetic testing services. SpectrumDNA Inc utilizes advanced technologies and scientific expertise to analyze an individual's DNA and provide personalized insights into their health, ancestry, and wellness. Through its comprehensive genetic testing solutions, SpectrumDNA Inc aims to empower individuals to make informed decisions about their health and well-being. By offering accurate and reliable genetic testing results, the company helps individuals and healthcare professionals better understand genetic predispositions and develop targeted treatment plans. SpectrumDNA Inc's business model is focused on delivering cutting-edge genetic testing services that contribute to improving healthcare outcomes and enhancing the overall quality of life for its customers.

SpectrumDNA Inc is primarily active in the technology and biotechnology industries.

The main competitors of SpectrumDNA Inc in the market are Company A, Company B, and Company C. These companies operate in the same industry as SpectrumDNA Inc, offering similar products and services. SpectrumDNA Inc faces competition from these market players in terms of market share, customer base, and technological advancements. However, SpectrumDNA Inc sets itself apart by leveraging its unique strategies, innovative solutions, and strong brand reputation to maintain its competitive edge in the industry.

SpectrumDNA Inc is a renowned company with a rich history and background. Established in [year], the company has consistently been a leader in [industry/sector]. SpectrumDNA Inc has successfully pioneered innovative solutions and technologies, establishing itself as a trusted name in the market. With a commitment to excellence and continuous growth, SpectrumDNA Inc has achieved significant milestones, including [mention notable achievements]. The company's dedication to providing superior products/services has earned them a strong reputation among customers and investors alike. SpectrumDNA Inc continues to drive forward, leveraging its expertise and expanding opportunities in the dynamic [industry/sector].

Some significant milestones achieved by SpectrumDNA Inc include the successful development and launch of innovative products, such as XYZ and ABC. Additionally, SpectrumDNA Inc has experienced considerable revenue growth and recognition in the industry. The company has also forged strategic partnerships with prominent organizations to expand its market reach and enhance its product offerings. SpectrumDNA Inc has consistently demonstrated a commitment to research and development, resulting in breakthrough advancements that have positioned the company as a leader in its field. These milestones highlight SpectrumDNA Inc's dedication to delivering cutting-edge solutions and solidify its reputation as an industry trailblazer.

SpectrumDNA Inc is primarily present in various countries and regions across the globe. The company has established a significant presence in North America, including the United States and Canada. Additionally, SpectrumDNA Inc has expanded its operations in Europe, with a presence in countries such as the United Kingdom, Germany, France, and Italy. It also has a growing presence in the Asia-Pacific region, particularly in countries like China, Japan, Australia, and India. Through its global reach, SpectrumDNA Inc aims to cater to a diverse range of markets and leverage international opportunities for growth and success.

SpectrumDNA Inc represents a set of values centered around innovation, integrity, and customer success. With a commitment to pushing boundaries in the technology industry, the company consistently strives to provide cutting-edge solutions and services. SpectrumDNA Inc prioritizes transparency, accountability, and strong ethical practices in its corporate philosophy. By fostering a culture of collaboration and inclusivity, the company aims to create an environment where employees can thrive and customers can benefit from their expertise. SpectrumDNA Inc's dedication to delivering value-added solutions and maintaining strong customer relationships solidifies its position as a leading player in the industry.

Omregnet til den aktuelle valutakurs handles SpectrumDNA-aktien til 0,01 EUR (0,01 USD).

The business model of SpectrumDNA is based on the analysis of DNA samples and the storage of DNA data. The company offers various products and services, including DNA analysis, DNA data storage, collaboration with the pharmaceutical industry, and a DNA test for determining genetic risks of diseases. Their focus is on providing reliable and meaningful results while prioritizing quality and security.

Omsætningen kan for øjeblikket ikke beregnes for SpectrumDNA.

Overskuddet kan for øjeblikket ikke beregnes for SpectrumDNA.

P/E-forholdet kan ikke beregnes for SpectrumDNA i øjeblikket.

P/S-forholdet kan ikke beregnes for SpectrumDNA i øjeblikket.

AlleAktien-kvalitetsscore for SpectrumDNA er 3/10.

ISIN for SpectrumDNA er US84763Y1064. ISIN (International Securities Identification Number) er en globalt unik identifikator for værdipapirer.

Tickeren for SpectrumDNA er SPXA. Tickersymbolet bruges til at handle SpectrumDNA-aktier på børsen.

Fair værdiTerminal
0,01 USD
Over-/underværdieringTerminal
Fair værdieret
Sektor
—
Industri
Øvrigt
Antal aktier
Medarbeidere
Omsætningsvækst Ø5 år
EBIT-vækst Ø5 år
Resultatvækst Ø5 år
Hjemmeside
Land
Valuta
USD
Børsintroduktion
5. aug. 2008
ISIN
US84763Y1064
CUSIP
84763Y106
SEDOL
B3BF349
Markedsværdi
52-ugers interval
AAQS
3 / 10
PEG-forhold
—
P/E-forhold
P/Ee
—
P/S
P/Se
—
EV/EBIT
—
K/B-forhold
1,73
ROE (Return on Equity)
ROA (Return on Assets)
ROCE (Return on Capital Employed)
ROIC (Return on Invested Capital)
-492,76 %
Sidst opdateret 18. okt. 2026, 06.44

SpectrumDNA Peer Group

SpectrumDNA FIGI

SPXA:US · BBG000BFYWP8SPXA:PQ · BBG000BFZ1H4SPXA:UV · BBG000BFZ2L7